Research Topic

New Insights in the Landscape of Rare Tumors: Translational and Clinical Research Perspective

About this Research Topic

Rare tumors represent a heterogeneous group of solid and liquid malignancies with uncertain etiology, classification, and clinical behavior. The incidence is estimated at less than 6 in 100000 people per year. Despite their low incidence, rare cancers represent 20-25% of all neoplasms with almost 250 ...

Rare tumors represent a heterogeneous group of solid and liquid malignancies with uncertain etiology, classification, and clinical behavior. The incidence is estimated at less than 6 in 100000 people per year. Despite their low incidence, rare cancers represent 20-25% of all neoplasms with almost 250 different entities. Outcomes in patients with rare cancers are worse than those in patients with more common tumor types. This is mainly caused by difficulties or delays in diagnosis, limited access to centers with clinical expertise, less effective standard treatments, and inadequate funding for preclinical and clinical research programs. Rare cancers are thus a significant public health issue and an urgent need exists to better understand the natural history, explore prognostic and predictive biomarkers, develop novel therapies and facilitate clinical trials for these marginalized diseases. Innovative treatments are often not easily available for these rare cancers, even though some of them have been paradigmatic models for targeted therapies of cancer (e.g. gastrointestinal stromal tumor [GIST]).

In order to answer these unmet scientific and clinical needs, a strong collaboration between clinicians and laboratory researchers grouped in multidisciplinary cancer teams is required, along with a research network between several institutions. These could potentially lead to a larger enrolment of rare cancer patients into translational and clinical studies.

This Research Topic aims to give a comprehensive overview of key areas of research focus and future perspectives in rare cancer research (head and neck cancers, neuroendocrine neoplasia and endocrine glands tumors, soft tissue sarcoma, central nervous system neoplasms) while focusing on preclinical, translational and clinical studies. Topics should include but are not limited to:

1) Gene expression profiling and preclinical pharmacology on rare tumors using immortalized cell lines and primary cultures in vitro and in vivo
2) Preclinical investigation on the mechanism of action of innovative drugs or innovative chemotherapy regimens for rare cancers treatment
3) Prognostic and Predictive biomarkers: From Bench To Bed
4) Optimization Of Diagnostic Pathways In Rare Cancer
5) Advanced Clinical Practice: Challenges and Therapeutic Opportunities
6) New Drugs, New Side Effects: Complications of Cancer Immunotherapy and TKIs
7) Clinical Epidemiology: Understand The Natural History Of Rare Cancer

We welcome Original Research, Review, Mini Review, Clinical Trial, Case Report, Data Report, Opinion and Study Protocol articles.

TI has received honoraria from Eisai as consultant and grants or funding to his institution from Novartis.
TI participated in congress which travel and accommodations were paid by Ipsen, Pharmamar, and Novartis.


Keywords: rare tumors, pharmacology, chemotherapy, network, gene expression profiling, immunotherapy, epidemiology, toxicity


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

29 November 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

29 November 2019 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..

Comments

Loading..

Add a comment

Add comment
Back to top